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This study is a complementary study to our previous study that included the synthesis and characterization of some 
maleanilic acid derivative ligands (L1-4) and their metal carbonyl complexes (2-4)a-d as effective compounds for cancer cell 
growth inhibition against three cancer cell lines: HCT-116, HepG-2 cells and MCF-7. The activity data has manifested that 
the p-nitrophenyl maleanilic acid ligand (L2) and its chromium complex (2b) inhibited the tested cancer cells more 
effectively than the other complexes. Additionally, DFT and TD-DFT studies are performed to investigate their frontier 
molecular orbital (FMO), optical properties, and the correlation between the structure and biological activity. The calculated 
optical energy gap (Eg) is in the range of 1.78- 2.13 eV, and electron cloud delocalization of HOMO/LUMO levels revealed 
that all complexes show effective charge separation. The DFT results show a strong relation between Eg values of the 
carbonyl complexes and their experimental biological activity, where it is obvious that complex (2b) with the lowest Eg 
value has the greatest inhibitory potency against cancer cells. In contrast, complex (2d) with the highest Eg value exhibits 
the lowest inhibition potency. These findings translate the inverse relationship between Eg values of the complexes and the 
inhibition potency against cancer cells.  
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In organometallic chemistry, the fabrication of new 
complexes plays a significant role in the evolution of 
organometallic complexes by obtaining unique 
properties and novel reactivity. Several major aspects 
must be taken in consideration on studying these 
metal complexes, such as: the active sites together 
with the functional groups of ligands, both the 
behaviour and the properties of the acceptor/ donor 
atoms of ligands, and the position of the ligand in the 
coordination sphere of a compound1-10. Transition 
metal carbonyl complexes have more attention in the 
last decades because of their role in luminescence and 
electron transfer reactions. Several of these complexes 
were observed as effective catalysts in catalytic 
reactions11 and in pharmacology as antioxidant, 
coenzyme and anticancer11-17. Moreover, in 
organometallic chemistry metal carbonyl complexes 
also act as starting materials for other complexes, 
because the CO ligands can be easily replaced in 
chemical or photochemical reactions18. The chemistry 
and reactivity of maleanilic acid derivatives have 
always been of great interest because of their 
biological activities. They can be used to prepare 
maleimides, which act as chemical probes of protein 
structure19, and they can also be used as preventative 
and curative fungicides20. Maleanilic acid derivatives 
play an important role in polymer chemistry because 
they can be used as photo initiators in free-radical 
polymerization21,22. They can also be used as 
monomers in polymaleimides or their copolymers 
synthesis. Maleimides find further application in the 
agricultural industry as herbicides and fungicides23. 
Furthermore, aryl-substituted of maleimides have 
been synthesized for use as new acetylcholinesterase 
inhibitors, which are being researched for the 
treatment of Alzheimer's disease24. On the other hand, 
the computational chemistry25 is rapidly growing 
which involves the use of home computers for the 
interpretation of experimental results26.  
In our previous work, we have synthesized some 
maleanilic acid derivatives as bidentate free ligands 
(p-methoxy phenyl, p-nitrophenyl, p-chloro phenyl 
and p-fluoro phenyl maleanilic acid). The prepared 
free ligands have chelated with the chromium group 
hexacarbonyls to give organometallic complexes of 
the formula [R(C6H4) NHCOCH=CH-COOH-M 
(CO)4]; in which (M = Cr, Mo, W) and (R= OCH3, 
NO2, Cl or F). All the free ligands and their 
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complexes were characterized using elemental 
analyses, mass spectrometry, FT-IR, 1H-NMR 
spectroscopy and thermal analyses27-29. In this study 
we mainly focused on studying the cytotoxic activity 
of the prepared maleanilic acid derivatives and their 
carbonyl complexes against three cancer cell lines in 
comparison with the theoretical calculations to 
confirm their life importance as health applications. 
Furthermore, DFT and TD-DFT studies were 
performed to obtain more information on 
HOMO/LUMO energy levels and to investigate the 
relationship between the energy gap (Eg) values 
of the complexes and the inhibition efficacy against 
cancer cells. 
Materials and Methods 
All the chemicals needed for this study were 
purchased from Sigma Aldrich (Germany) and Alpha 
Aesar. Those chemicals included Cr(CO)6, Mo(CO)6, 
W(CO)6, maleic anhydride, 4-methoxyaniline,  
4-nitroaniline, 4-chloroaniline, 4-fluoroaniline, DMF,
DMSO and absolute ethanol solvent.
Synthesis of the free ligands and their metal carbonyl 
complexes 
The maleanilic acid derivatives (L1-4) were 
prepared according to the procedures reported in the 
literature30 as shown in Scheme 1. Maleic anhydride 
9.8 g (0. 1 mol) and aniline derivatives (1a-d) (0.1 mol) 
were mixed and ground at room temperature in an 
agate mortar. The grinding was continued for 30-60 min. 
The crude products were crystallized from ethanol 
several times and the collected crystals were dried. On 
the other hand, the metal carbonyl complexes 
(2-4)a-d were prepared according to the procedures 
reported in the literatures27-29 as shown in Scheme 1 
by dissolving the free maleanilic acid derivatives 
ligands (L1-4) (0.5 mmol) in a few amount of DMF 
and then M(CO)6 (0.5 mmol) in the same solvent was 
added. The total volume was made to 20 mL with the 
same solvent. The obtained reaction mixture was 
stirred for 40-60 min at 90-100 ºC under reflux in an 
inert nitrogen atmosphere. The product was separated 
and washed thoroughly with ethanol several times and 
recrystallized from DMF / ethanol mixture. Finally 
the product was dried by means of P2O5 in a 
desiccator. All the free ligands and their complexes 
was confirmed by different spectral techniques 
such as FT-IR, 1H-NMR, elemental analysis, mass 
spectroscopy, and thermal analysis (see 
Supplementary Data, Tables S1-S3 & Figs. S1–S52).  
Cell culture and cytotoxicity determination 
Three human cancer cell lines; HCT-116 (colon 
cancer), HepG-2 cells (human hepatocellular cancer) 
and MCF-7 (human breast cancer) were obtained 
frozen in liquid nitrogen (-180 ) for in vitro 
screening experiments from Tissue Culture Unit 
(VACSERA). Serial sub-culturing was used to keep 
the tumor cell lines alive at the National Cancer 
Institute in Cairo, Egypt. Cell culture cytotoxicity 
assays were carried out as described previously18. 
DMEM medium was used for culturing and 
maintenance of the human tumor cell lines18.  
The cells were grown in DMEM and supplemented 
with 10% heat-inactivated fetal bovine serum, 1% 
L-glutamine, HEPES buffer and 50 µg mL-1
gentamycin. All of the cells were kept at 37  in a
humidified atmosphere with 5% CO2, and then
subcultured twice a week. The cells were seeded in
96-well plate at a cell concentration of 1×104 cells /
well in 100 µL of growth medium. After that, a fresh
medium with different concentrations of the tested
sample was added after one day of seeding. A
multichannel pipette was used to add serial two-fold
dilutions of the investigated chemical compound to
confluent cell mono layers dispensed into bottomed
micro titer plates (Falcon, NJ, USA). The micro titer
plates were incubated at 37  in a humidified
incubator with 5% carbon dioxide for two days. Three
wells were used for each concentration of the tested
sample. Control cells were incubated without test
sample and with / without DMSO. After cells
incubation at 37 °C, various concentrations of sample
were added and the incubation was continued for 24 h
Scheme 1 ― Synthesis of N-substituted maleanilic acid ligands
(L1-4) and metal carbonyl complexes (2-4)a-d, where: R=OCH3 
(L1); R=NO2 (L
2); R= Cl (L3); R=F (L4). M=Cr, R=OCH3 (2a);
M=Cr, R=NO2 (2b); M=Cr, R= Cl (2c); M=Cr, R=F (2d); M=Mo,
R=OCH3 (3a); M= Mo, R=NO2 (3b); M= Mo, R= Cl (3c);
M= Mo, R=F (3d); M=W, R=OCH3 (4a); M= W, R=NO2 (4b);
M= W, R= Cl (4c); M= W, R=F (4d) 




and viable cells yield was determined by the 
colorimetric method 31.   
 
Molecular modeling 
Equilibrium molecular geometries of (2-4)a-d 
complexes were calculated using density functional 
theory (DFT) utilizing Becke 3-Parameter 
(Exchange), Lee, Yang and Parr (correlation) 
(B3LYP) exchange correlation function and SDD 
function basis set. Also, the vertical excitation energy 
and their response (UV–visible absorption) in the 
excited complexes were computed using TD-DFT 
calculations at CAM-B3LYP/SDD. All DFT and TD-
DFT calculations were carried out using Gaussian 09 
program package32.  
 
Results and Discussion  
 
Biological activity 
The cytotoxic activity of chromium carbonyl 
chelates of the type [R(C6H4) NHCOCH=CH-COOH-
Cr(CO)4]; which R = (NO2, Cl or F) and the 
corresponding ligands against cell lines of HCT-116, 
hepG-2 and MCF-7 was evaluated by viability assay. 
The concentrations of them ranged from 3.9 µg mL-1 
to 500 µg mL-1, the inhibitory percentage against 
growth of cancer cells was determined. The IC50 
values obtained for ligands and their chelates against 
selected three tumor cell lines are shown in Table 1, 
the toxicity of the ligands and chelates was found to 
be concentration dependent, the cell viability 
decreased with increasing the concentration of them 
against the tested cancer cell lines. The biological 
activities of L2-4 free ligands and their chromium 
complexes are presented in Figs. S53-S69, 
Supplementary Data.  
 
Cytotoxic activity of the free ligands 
Cytotoxicity in vitro of p-nitrophenyl maleanilic 
acid free ligand L2 has been estimated by MTT assay 
against three typical human tumor cell lines involving 
HepG-2, MCF-7 and HCT-116. The results are 
presented in Fig. 1a. The results of inhibitory rate of 
p-nitrophenyl maleanilic acid free ligand show 
remarkable cytotoxicity (IC50) against the selected 
human cancer cell lines in the following order: HepG-
2 (15.1µg mL-1) > MCF-7 (25.9 µg mL-1) > HCT-116 
(26.7 µg mL-1). While, p-chlorophenyl maleanilic acid 
free ligand L3 introduced lower inhibitory activity 
against the three selected human tumor cell lines 
as shown in Fig. 1b, compared to the inhibitory 
activity of p-nitrophenyl maleanilic acid L2. This is 
due to the lower electronegativity of chloro-group in 
L3 compared to that of nitro group in L2. Moreover, 
the results of inhibitory rate of p-nitrophenyl 
maleanilic acid free ligand showed a higher 
cytotoxicity against the selected human cancer cell 
Table 1 ― Influence of the compounds on the viability of  
MCF-7, HepG-2 and HCT-116 cell lines 
 
Compound 
In vitro cytotoxicity IC50 (µg mL
-1) 
HepG-2 MCF-7 HCT-116 
L2 15.1 25.9 26.7 
L3 123 95.2 60.4 
L4 60.4 56.2 53.7 
2b 27.3 30.1 29.6 
2c 91.2 163 236 
2d >500 >500 >500 
 
 
Fig. 1 — Cell viability of ligands (a) L2, (b) L3 and (c) L4, against
the three tested cell lines  




lines compared to that of L2 and has the following 
order: HCT-116, (60.4 µg mL-1) > MCF-7 (95.2 µg 
mL-1) > HepG-2 (123 µg mL-1). Furthermore, 
evaluation of the efficacy of p-fluorophenyl 
maleanilic acid free ligand L4 as inhibitor revealed a 
higher potency against HepG-2, MCF-7and HCT-116 
human cancer cell lines, compared to that of  
p-chlorophenyl maleanilic acid free ligand L3 as 
shown in Fig. 1c. This is attributed to the replacement 
of the less electronegative 4-chlorophenyl moiety of  
p-chlorophenyl maleanilic acid free ligand L3 with 
the more electronegative 4-fluorophenyl moiety of  
p-fluorophenyl maleanilic acid free ligand resulted in 
enhancement of the inhibitory activity. The calculated 
IC50 of L
4 showed lower values than that of L3 and 
have the following order: HCT-116 (53.7 µg mL-1) > 
MCF-7 (56.2 µg mL-1) > HepG-2, (60.4 µg mL-1) as 
shown in Table 1. Finally, the cytotoxic activity of 
the free ligands L2-4 was found to be in the order  
L2 > L4 > L3 depending on the electronegativity of the 
para position substituents in the free ligand.  
 
Cytotoxic activity of metal complexes  
The cytotoxic activity of all chelates of the type 
of [R(C6H4)NHCOCH=CH-COOH-Cr(CO)4]; where,  
R = (NO2, Cl or F) against cell lines of HCT-116, 
HepG-2 and MCF-7 was evaluated by viability assay. 
The cell viability (%) obtained with continuous 
exposure for 24 h at different concentrations ranging 
from (0-500 µg mL-1) is depicted in Fig. 2. Treatment 
of the cell lines with [O2N(C6H4) NHCOCH=CH-
COOH-Cr (CO)4] leads to significant decrease in the 
cell viability of the tested cell lines with increasing 
the concentration of it, as shown in Fig. 2a. The IC50 
values are 27.3, 30.1 and 29.6 µg mL-1 for HepG-2, 
MCF-7 and HCT-116 cell lines, respectively, these 
values of IC50 of [O2N(C6H4) NHCOCH=CH-COOH-
Cr (CO)4] complex are slightly less than that of L
2 
free ligand, as shown in Table 1. The cytotoxic 
activity of [Cl(C6H4)NHCOCH=CH-COOH-Cr 
(CO)4] against cell lines of HepG-2, MCF-7 and 
HCT-116 was evaluated and depicted in Fig. 2b. The 
IC50 values are 91.2, 163 and 236 µg mL
-1 for  
HepG-2, MCF-7 and HCT-116 cell lines, 
respectively, Table 1. The calculated IC50  
values of [Cl(C6H4) NHCOCH=CH-COOH-Cr(CO)4] 
illustrated that the [Cl(C6H4)NHCOCH=CH-COOH-
Cr(CO)4] demonstrated lower inhibitory activity 
against the tested cell lines comparing to the 
corresponding L3 free ligand except for HepG-2 cell 
line, the [Cl(C6H4)NHCOCH=CH-COOH-Cr(CO)4] 
has higher inhibitory activity than the L3 free ligand. 
The cytotoxic activity of [F(C6H4)NHCOCH=CH-
COOH-Cr(CO)4] was assayed and depicted in Fig. 2c. 
The IC50 values were estimated from the respective 
dose response curve and are summarized in Table 1. 
The resulted data obtained from the cytotoxic activity 
assay of [F(C6H4)NHCOCH=CH-COOH-Cr (CO)4] 
illustrated that the inhibitory potency of the L4 free 
ligand was obviously weakened when complexed 
with Cr(CO)6. In conclusion, the free ligands (L
2-4) 
outperformed the corresponding chromium complexes 
(2b-c) in terms of inhibitory potency against the 
tested cell lines. 
 
Fig. 2 ― Cell viability of complexes (a) 2a, (b) 2c and (c) 2c,
against the three tested cell lines  




The comparison of the inhibitory activity of  
p-nitrophenyl maleanilic acid (L2), p-chlorophenyl 
maleanilic acid (L3), and p-fluorophenyl maleanilic 
acid (L4) derivative ligands against the detected cell 
lines result in, p-nitro maleanilic acid and exhibits the 
highly inhibitory activity against the three selected 
human tumor cell lines. The IC50 values are  
15.1 µg mL-1, 25.9 µg mL-1 and 26.7 µg mL
-1 for 
HepG-2, MCF-7 and HCT-116, respectively. L4 has 
the second potency with IC50 values of 56.2, 60.4 and 
53.7 µg mL-1 for HepG-2, MCF-7 and HCT-116 
human cancer cell lines, respectively, while ,  L3 has 
the least potential for all the selected cell lines. The 
high activity of L2 may be assigned to the high 
electronegativity of nitro substituent of the ligand 
followed by L4 of high electronegativity and the 
small size, then L3 ligand is cleared the least activity 
one because it has less electronegativity. On the 
other hand, among the chromium chelates (2b-c), the 
p-nitrophenyl maleanilic acid chromium carbonyl 
chelate (2b) exhibits the highest inhibition potency 
against the tested cell lines, whereas, the chromium 
chelate of p-fluorophenyl maleanilic acid (2d) 
exhibits the least inhibitory activity. It was obvious 
that, the potency of the p-chlorophenyl maleanilic 
acid ligand with chromium metal (2c) against HepG-2 
cell lines has been improved compared to the  
free ligand (L3).  
 
Molecular modeling of (2-4) a-d complexes 
The quantum estimations are viewed as one of the 
most dependable computational methodologies in the 
field of chemistry. The DFT calculations were done 
for complexes (2-4)a-d at B3LYP energy functional 
and basis set (SDD) utilizing Gaussian 09 software. 
The Fermi Molecular Orbitals (FMO) of the 
complexes indicates the effective charge separation in 
HOMO-LUMO energy levels as depicted in Table 2. 
As expected, in their HOMO orbitals, the electron 
cloud is predominantly more accumulated on the 
donor part of complexes (2-4)a-d which includes the 
metal (Cr, Mo, W) and the carbonyl groups with come 
electron density on the aromatic ring. While, the 
LUMO levels for complexes (2-4)a-d the electron 
cloud is shifted evidently from the electron donor to 
the electron acceptor which represents the metal (Cr, 
Mo, W) and the synthesized ligands (L1-4), but  
in different extent depends up on the nature of  
the substituted groups (P-OCH3, NO2, F, Cl) on the 
ligand molecules.  
DFT calculations were performed to evaluate the 
HOMO LUMO levels and the optical energy gap (Eg) 
as shown in Table 3. The optical energy gap (Eg) was 
calculated using the formula Eg = EHOMO - ELUMO. 
From the Eg values it was observed that there is a 
great relation between the Eg values and the nature of 
the substituted groups such as (OCH3, NO2, Cl, F) on 
the ligand molecules. The Eg values of all complexes 
were found to be of the following order F > Cl > 
OCH3 > NO2. Moreover, the nature of metals  
(Cr, Mo, W) play a vital role in the Eg values which 
follow the order of Cr > Mo > W, as observed in Fig. 3. 
These Eg values were reflected in the light absorption 
characteristics of the molecules which showed the 
tungsten based complexes (Eg= 1.78-1.79 eV) absorbs 
light radiation in a wider range compared to the 
chromium (Eg= 2.11-2.13 eV) and molybdenum  
(Eg= 1.96-1.98 eV) based complexes. In conclusion, 
theoretically, the donating properties of the studied 
complexes as indicated from the computed EHOMO 
follow the order of the following substituent  
OCH3 > Cl > F > NO2. Meanwhile, they can be 
arranged according to the metals to have the 
following order W > Mo > Cr. 
TD-DFT for complexes (2-4)a-d have been 
performed to check their lowest singlet-singlet 
electronic excitation energy (E0-0) and UV-visible 
absorption spectra and the findings are summarized in 
Table 4 and Fig. 4. The TD-DFT was performed on 
the optimized structure at CAM-B3LYP & SSD basis 
set and the solvent effect was neglected. It was 
evident from the TD-DFT measurements that the 
calculated absorption spectra of the complexes 
showed two regions of bands in the range 310–395 nm 
due to π–π* electronic transitions and the other bands 
in the range 505–570 nm, which could be due to 
metal-to-ligand charge transfer as for the chromium 
complex (Cr, dπ-π*) or due to ligand-to-metal charge 
transfer as for molybdenum and tungsten complexes 
(π*-M, dπ)33 From the results, it was obvious that 
ligand-to-metal charge transfer of tungsten complexes 
(4a-d) are bathochromic shifted by an average of 
Δλmax=60 nm corresponding to molybdenum 
complexes (3a-d) and an average of Δλmax=47 nm 
corresponding to metal-to-ligand charge transfer of 
chromium complexes (2a-d). The maximum 
electronic absorption spectra can be arranged 
according to the metals size to have the following 
order W > Mo > Cr. Thus, in the case of tungsten 
complexes (4a-d), it would show significant  
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Table 2 ― Fermi molecular orbitals for complexes (2-4)a-d 
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Complex
Table 2 ― Fermi molecular orbitals for complexes (2-4)a-d  (contd.) 
Optimized Structure HOMO LUMO
4c 
4d 
Table 3 ― HOMO, LUMO, the optical energy gap (Eg) and dipole moment (µ) values for complexes (2-4)a-d computed by  













2a -0.22431 -6.103788 -0.14611 -3.97585 2.12793 8.5700
2b -0.23970 -6.522571 -0.16205 -4.40960 2.11297 8.7159
2c -0.23157 -6.301342 -0.15321 -4.16905 2.13229 7.2133
2d -0.23162 -6.302703 -0.15324 -4.16987 2.133653 7.2523
3a -0.22119 -6.018888 -0.14885 -4.05041 1.968478 9.2082
3b -0.23649 -6.435223 -0.16440 -4.47355 1.961673 9.1887
3c -0.22841 -6.215354 -0.15573 -4.23763 1.977724 7.8104
3d -0.22855 -6.219164 -0.15573 -4.23763 1.981534 7.8477
4a -0.21762 -5.921744 -0.15217 -4.14075 1.780994 9.6788
4b -0.23265 -6.330731 -0.16722 -4.55028 1.780451 9.4220
4c -0.22470 -6.114400 -0.15886 -4.32280 1.7916 8.1949
4d -0.22492 -6.120387 -0.15887 -4.32307 1.797317 8.2177
bathochromic shifts perhaps due to high charge 
density and consequently strong bonding with the 
ligand molecule compared to that of chromium (2a-d) 
and molybdenum (3a-d) complexes.34 The absorption 
spectra of the complexes confirm the effect of 
changing the metal (M) on the position of the visible 
absorption of the complexes. On the other hand, 
Tungsten complexes showed a good maximum molar 
absorptivity in the range of (2306–2482 M-1 cm-1) 
compared to that of molybdenum (1893–2010 M-1 cm-1) 
and chromium complexes (1415–1338 M-1 cm-1). 
Among all metal complexes, the complexes 
incorporating nitro substituted ligand achieved the 
highest molar absorptivity compared to other 
complexes of the same metal. 
The relation between Eg-values of the complexes and 
biological activity 
The comprehensive study of the molecular 
modelling and the cytotoxicity of the chromium 
carbonyl complexes of some selected ligands (L2-4) it 
was obvious that, there is a great relation between 
Eg of the carbonyl complexes and their biological 
activity towards HCT-116, HepG-2 and MCF-7 cells. 
It is well known that the Eg values have a relative 
effect on the reactivity of the drugs or complexes 
under consideration. The greater the energy gap, the 
lower the corresponding hardness values, implying 
Fig. 3 ―Plots for the relation between Eg, the nature of ligands
and metals 




high reactivity of the investigated complexes35,36. This 
is due to the molecules' increased ability to accept 
electrons more readily, which will most likely be 
reflected in their reactivity36. It should be noted, 
however, that while energy gap and hardness 
parameters correlate with a molecule's chemical 
reactivity in general, they do not always reflect its 
biological activity, as the latter is dependent on a 
variety of other parameters and effects35. The 
molecular modelling results show that, the Eg of the 
chromium complexes follow the order of 2d (2.133 
eV) > 2c (2.132 eV) > 2b (2.112 eV), which is the 
same order for the decreasing complexes potency 
towards the cancer cells as 2d < 2c < 2b. This gives 
an interpretation of the decreasing of the Eg of the 
metal chelate enhance the potency of it to the cancer 
cells. In conclusion, the p-nitrophenyl maleanilic 
acid metal carbonyl complex (2b) exhibits the 
highest inhibition potency against the tested cell lines. 
Meanwhile, the chelation of p-chlorophenyl 
maleanilic acid ligand with chromium metal (2c) 
makes it highly active than the free ligand and the 
metal complex of p-fluorophenyl maleanilic acid 
exhibits the least inhibitory activity (2d). This 
explains the importance of designing chromium 
complexes incorporating highly electronegative 
groups and with lower Eg in order to enhance its 
efficiency to cancer cells. Furthermore, the TD-DFT 
study showed a relation between molar absorptivity of 
the carbonyl complexes and their biological activity 
towards selected cell lines. Where, the TD-DFT 
results show that, the molar absorptivity of metal-to-
ligand charge transfer (π*-dπ) for chromium 
complexes follow the order of 2b (1415.78 M-1 cm-1) > 
2c (1381.45 M-1 cm-1) > 2d (1362.68 M-1 cm-1), which 
is the same order for the increasing complexes potency 
towards the cancer cells as follow 2b > 2c > 2d. This 
explains the potency of the complex to the cancer cells 
enhanced by increasing the molar absorptivity of the 
metal chelate. Moreover, the outstanding molar 
absorptivity of tungsten complexes (4a-d) makes it a 
promising candidate for cancer cells. 
Table 4 ― Maximum absorption wavelength (λ), Molar absorptivity (ε), oscillator strength (f) and the first excitation energy (E0-0), values 
for complexes (2-4)a-d computed at CAM-B3LYP and SSD basis set 
Metal Complex λ (nm) ε (M
-1cm-1) f E0-0 (eV) 
 
Cr 
2a 362 (π–π*) 




2b 358 (π–π*) 




2c 342 (π–π*) 




2d 347 (π–π*) 






3a 384 (π–π*) 




3b 313 (π–π*) 




3c 322 (π–π*) 




3d 320 (π–π*) 






4a 394 (π–π*) 









4c 324 (π–π*) 




4d 321 (π–π*) 









Four maleanilic acid derivatives incorporating  
(p-methoxy phenyl, p-nitrophenyl, p-chloro phenyl 
and p-fluoro phenyl maleanilic acid) were used as 
bidentate free ligands for the synthesis of different 
metal carbonyl complexes of the formula [R(C6H4) 
NHCOCH=CH-COOH-M(CO)4]. The cytotoxic 
activity of some selected maleanilic acid ligands 
incorporating p-nitrophenyl, p-chloro phenyl, and  
p-fluoro phenyl (L2-4) have been examined for 
anticancer activities against HepG-2, MCF-7 and 
HCT-116 cancer cells and achieved an efficacy in the 
order of L2 > L4 > L3 depending on the 
electronegativity of the para position substituents in 
the ligand. Meanwhile, the cytotoxic activity of their 
chromium carbonyl complexes (2b-c) on the same 
cancer cells were in the order of 2b>2c>2d. In 
general, the overall inhibition potency of the free 
ligands (L2-4) against cancer cells outperformed that 
of the corresponding chromium complexes (2b-c), 
with the exception of the p-chlorophenyl maleanilic 
acid ligand with chromium metal (2c) against HepG-2 
cell lines, which has been improved over the free 
ligand (L3). These results have been confirmed from 
the comprehensive study of both DFT/TD-DFT and 
the cytotoxicity of the metal carbonyl complexes  
(2-4)a-d. It was obvious that the complexes 
incorporating nitro groups e.g. (2b) achieved the 
lowest Eg, the highest molar absorptivity values and 
shows the highest inhibition potency against the three 
tested cell lines and vice versa with complexes 
incorporating fluorine atom e.g. (2d) that 
demonstrated the significant concordance between the 
Eg of the complexes and their experimental biological 
activity. In summary, we have recommended the 
importance of designing chromium complexes from 
ligands of maleanilic acid derivatives that incorporate 
high electronegativity groups with low Eg and high 
molar absorptivity in order to enhance their efficacy 
on cancer cells.  
 
Supplementary Data 
Supplementary Data associated with this article are 





The authors are thankful to Regional Center for 
Mycology & Biotechnology, Al-Azhar University, 




1 Amini M M, Najafi E, Babaei M, Ghahramani K &  
Khavasi H R, Monatshefte fur Chemie, 147 (2016) 1547. 
2 Bharty M K, Paswan S, Dani R K, Singh N K, Sharma V K, 
Kharwar R N & Butcher R J, J Mol Struct, 1130 (2017) 181. 
3 Calu L, Badea M, Chifiriuc M C, Bleotu C, David G I,  
Ioniţă G, Măruţescu L, Lazăr V, Stanică N, Soponaru I, 
Marinescu D & Olar R, J Therm Anal Calorim, 120 (2015) 
375. 
4 Ledeţi I, Vlase G, Vlase T, Bercean V & Fuliaş A, J Therm 
Anal Calorim, 121 (2015) 1049. 
 
 
Fig. 4 ― Calculated UV-visible absorption spectra of (2-4)a-d
complexes at CAM-B3LYP/SDD 




5 Lintnerová L, Valentová J, Herich P, Kožíšek J & Devínsky F, 
Monatshefte für Chemie - Chem Mon, 149 (2018) 901. 
6 Mandal M, List M, Teasdale I, Redhammer G, Chakraborty 
D & Monkowius U, Monatshefte für Chemie - Chem Mon, 
149 (2018) 783. 
7 Murthy Y L N, Govindh B, Diwakar B S, Nagalakshmi K & 
Rao K V R, Med Chem Res, 21 (2012) 3104. 
8 Najafi E, Amini M. M, Taherbateni S, Memarian H &  
Ng S W, Monatshefte für Chemie - Chem Mon, 149 (2018) 
1379. 
9 Zayed E M, Zayed M A & El-Desawy M, Spectrochim Acta 
A, 134 (2015) 155. 
10 Zhai Q G, Hu M C, Wang Y, Ji W J, Li S N & Jiang Y C, 
Inorg Chem Commun, 12 (2009) 286. 
11 Kimmich B F M, Fagan P J, Hauptman E, Marshall W J & 
Bullock R M, Organometallics, 24 (2005) 6220. 
12 Bandarra D, Lopes M, Lopes T, Almeida J, Saraiva M S, 
Vasconcellos-Dias M, Nunes C D, Félix V, Brandão P,  
Vaz P D, Meireles M & Calhorda M J, J Inorg Biochem, 104 
(2010) 1171. 
13 Datta P, Mukhopadhyay A P, Manna P, Tiekink E R, Sil P C 
& Sinha C, J Inorg Biochem, 105 (2010) 577. 
14 Glans L, Taylor D, de Kock C, Smith P J, Haukka M, Moss J R 
& Nordlander E, J Inorg Biochem, 105 (2011) 985. 
15 Zhang W-Y, Banerjee S, Hughes G M, Bridgewater H E, 
Song J-I, Breeze B G, Clarkson G J, Coverdale J P C, 
Sanchez-Cano C, Ponte F, Sicilia E & Sadler P J, Chem Sci, 
11 (2020) 5466. 
16 Huang H, Banerjee S, Qiu K, Zhang P, Blacque O, 
Malcomson T, Paterson M J, Clarkson G J, Staniforth M, 
Stavros V G, Gasser G, Chao H & Sadler P J, Nat Chem, 11 
(2019) 1041. 
17 Huang C, Liang C, Sadhukhan T, Banerjee S, Fan Z, Li T, 
Zhu Z, Zhang P, Raghavachari K & Huang H, Angew 
Chemie Int Ed, 60 (2021) 9474. 
18 Arifin K, Daud W R W & Kassim M B, Ceram Int, 39 (2013) 
2699. 
19 Corrie J E T, J Chem Soc Perkin Trans 1 (1994) 2975. 
20 Fujinami A, Ozaki T, Nodera K & Tanaka K, Agr Biol 
Chem, 36 (2014) 318. 
21 Boyd P D W, Challis J B & Rickard C E F, Acta Crystallogr 
Sect E: Struct. Rep. Online, 62 (2006) m2732. 
22 Rich D H, Gesellchen P D, Tong A, Cheung A &  
Buckner C K, J Med Chem, 18 (1975) 1004. 
23 Bastin L D, Nigam M, Martinus S, Maloney J E, Benyack L L 
& Gainer B, Green Chem Lett Rev, 12 (2019) 127.  
24 Trujillo Ferrara J, Correa Basurto J, Espinosa J, García J, 
Martínez F & Miranda R, Synth Commun, 35 (2006) 2017. 
25 Mulholland P & Dundas D, Phys Rev A, 97 (2018) 043428. 
26 Mura P, Faucci M T, Maestrelli F, Furlanetto S & Pinzauti S, 
J Pharm Biomed Anal, 29 (2002) 1015. 
27 Oraby K R, Zayed M A, Hassan F S M & Mohamed A E,  
J Transit Met Complexes, 2020 (2020) 1. 
28 Zayed M A, Hassan F S M, Mohamed A E & Oraby K R,  
J Transit Met Complexes, 2018 (2018) 1. 
29 Zayed M A, Oraby K R & Hassan F S M, Egypt J Chem, 63 
(2020) 4327. 
30 Saedi H, Bull Chem Soc Ethiop, 27 (2013) 137. 
31 Mosmann T, J Immunol Methods, 65 (1983) 55. 
32 Frisch M, Trucks G, Schlegel H, Scuseria G, Robb M, 
Cheeseman J, Scalmani G, Barone V, Petersson G & 
Nakatsuji H, Gaussian 16, Gaussian, Inc. Wallingford, CT, 
(2016). 
33 El-Medani S M, J Coord Chem, 57 (2006) 497. 
34 Panhwar Q K & Memon S, Sci World J, 2014 (2014) 
845208.  
35 Piechowska K, Mizerska-Kowalska M, Zdzisińska B, 
Cytarska J, Baranowska-Łączkowska A, Jaroch K, 
Łuczykowski K, Płaziński W, Bojko B, Kruszewski S, 
Misiura K & Łączkowski K. Z, Int J Mol Sci, 21 (2020) 1. 
36 Mishra A K & Tewari S P, SN Appl Sci, 2 (2020) 1. 
 
